Dr. Sun is a professor and surgeon at the First Affiliated Hospital of Anhui Medical University where he serves as the president of the hospital. In 2001, he obtained his MD-PhD degree in Nanjing Medical University, China. As a postdoctoral fellow at The University of Texas Health Science Center at San Antonio, he devoted his time to telomerase-related cancer research. As a surgeon, he is skilled in liver transplantation and Hepatectomy.

Dr. Sun's research is mainly focused on inflammatory-related carcinogenesis. His team discovered the potential therapeutic values and mechanistic roles of cytokines in hepatocarcinogenesis including IL-22, IL-17A, and IL-1α, etc. His team also explored the micro-environment in liver cancer, and found the tumor draining lymph nodes (TdLNs) -derived tumor-specific memory (TTSM) cells established memory-associated epigenetic program early during tumorigenesis. Meanwhile, Dr. Sun has also pioneered many world leading landmark surgeries, such as adult-to-adult liver transplantation using an otherwise discarded partial liver allograft, liver xeno-transplantation using 10 genes modified pig in a living liver cancer patient.

Dr. Sun is the Yangtze River Scholar Professor of Chinese Ministry of Education, and he also obtained a National Science Fund for Distinguished Young Scholars. He is an Associate Editor of Plos One and Associate Editor of World Journal of Gastroenterology, a member of the Youth Committee of Chinese Organ Transplantation Society of Chinese Medical Association and the Executive Committee of Chinese Society of Liver Cancer, Chinese Anti-Cancer Association.